SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19272734
Source:
http://linkedlifedata.com/resource/pubmed/id/19272734
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0205178
,
umls-concept:C0449445
,
umls-concept:C0520997
,
umls-concept:C0948008
pubmed:issue
2
pubmed:dateCreated
2011-8-12
pubmed:abstractText
The drip-and-ship method of treating stroke patients may increase the use of tissue plasminogen activator (t-PA) in community hospitals.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/5-T32-NS007412-09
,
http://linkedlifedata.com/resource/pubmed/grant/P50 NS044227-019002
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8412174
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0736-4679
pubmed:author
pubmed-author:AbrahamAnithaA
,
pubmed-author:BarretoAndrew DAD
,
pubmed-author:GrottaJames CJC
,
pubmed-author:HalleviHenH
,
pubmed-author:JonesElizabethE
,
pubmed-author:KhajaAslam MAM
,
pubmed-author:Martin-SchildSherylS
,
pubmed-author:MoralesMiriam MMM
,
pubmed-author:SavitzSean ISI
,
pubmed-author:SlineM RickMR
pubmed:copyrightInfo
Copyright © 2011 Elsevier Inc. All rights reserved.
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
135-41
pubmed:meshHeading
pubmed-meshheading:19272734-Acute Disease
,
pubmed-meshheading:19272734-Aged
,
pubmed-meshheading:19272734-Brain Ischemia
,
pubmed-meshheading:19272734-Clinical Protocols
,
pubmed-meshheading:19272734-Female
,
pubmed-meshheading:19272734-Fibrinolytic Agents
,
pubmed-meshheading:19272734-Hospital Mortality
,
pubmed-meshheading:19272734-Humans
,
pubmed-meshheading:19272734-Infusions, Intravenous
,
pubmed-meshheading:19272734-Logistic Models
,
pubmed-meshheading:19272734-Male
,
pubmed-meshheading:19272734-Middle Aged
,
pubmed-meshheading:19272734-Outcome Assessment (Health Care)
,
pubmed-meshheading:19272734-Retrospective Studies
,
pubmed-meshheading:19272734-Stroke
,
pubmed-meshheading:19272734-Thrombolytic Therapy
,
pubmed-meshheading:19272734-Time Factors
,
pubmed-meshheading:19272734-Tissue Plasminogen Activator
,
pubmed-meshheading:19272734-Transportation of Patients
,
pubmed-meshheading:19272734-United States
pubmed:year
2011
pubmed:articleTitle
Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?
pubmed:affiliation
Department of Neurology, University of Texas-Houston Health Science Center, Houston, Texas, USA.
pubmed:publicationType
Journal Article
,
Research Support, N.I.H., Extramural